A Harvard Medical School study found advanced AI systems outperformed doctors in emergency room diagnoses under controlled testing. Researchers say AI could become a powerful decision-support tool, improving diagnostic accuracy while complementing, not replacing human clinicians.
Osun State and UNICEF are advancing digital learning and AI solutions to reduce the number of out-of-school children. Through collaboration, innovation and skills development, stakeholders aim to create inclusive education opportunities that prepare every child for a brighter digital future.
China has approved the NEO brain chip for mass production and patient use, marking a major milestone in brain-computer interface technology. The device helps paralyzed patients control digital devices with their thoughts and reaches commercialization ahead of Neuralink.
China has approved the NEO brain chip for mass production and patient use, marking a major milestone in brain-computer interface technology. The device helps paralyzed patients control digital devices with their thoughts and reaches commercialization ahead of Neuralink.
A Harvard Medical School study found advanced AI systems outperformed doctors in emergency room diagnoses under controlled testing. Researchers say AI could become a powerful decision-support tool, improving diagnostic accuracy while complementing, not replacing human clinicians.
Osun State and UNICEF are advancing digital learning and AI solutions to reduce the number of out-of-school children. Through collaboration, innovation and skills development, stakeholders aim to create inclusive education opportunities that prepare every child for a brighter digital future.
SpaceX's stock market debut has reportedly propelled Elon Musk beyond the $1 trillion net worth milestone while valuing the company above $2 trillion. The historic IPO highlights investor confidence in space technology, Starlink, and the future of commercial space exploration.
SpaceX is expected to debut on Nasdaq on June 12 under ticker SPCX, giving Nigerian investors a chance to own shares in one of the world's most valuable companies. While the opportunity is historic, analysts warn that a high valuation and expected volatility make caution essential.
Artificial intelligence is revolutionizing genomics by speeding up genetic analysis, enabling precision medicine, improving drug discovery, and supporting large-scale health research. AI is helping deliver earlier diagnoses, more effective treatments, and better healthcare outcomes worldwide.
Researchers at the University of Cambridge and DIOSynVax have developed an AI-powered vaccine platform designed to protect against entire virus families. Early trial results show strong safety and immune responses, raising hopes for broader disease prevention and pandemic preparedness.
Reports claim Anthropic may be valued near $900B, sparking debate across the tech world. Though unverified, the buzz highlights massive investor interest in AI, innovation, and the future of responsible artificial intelligence development globally.
